Remove Compounding Remove Documentation Remove Omnicell
article thumbnail

Why IV Automation Is Critical for Sterile Compounding

Omnicell

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell Imagine if Amazon lost one out of every 10 packages. So why, as clinicians, are we not focused on improving the documented one in 10 inaccuracies in sterile compounded products? Or the airlines lost 10% of passenger bags.

article thumbnail

From Pandemic to Epidemic: A Front Line Perspective on COVID-19 and the Opioid Crisis

Omnicell

Joy Somogyi Senior Director of Product Marketing and Development, Omnicell With two million people suffering from opioid addiction and 115 people dying from an opioid overdose every day in the U.S., the opioid crisis is one of the major challenges healthcare is facing, specifically for pharmacies currently managing medication diversion.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How Technology Can Support Health System Pharmacy with COVID-19 Vaccine Management 

Omnicell

Howard Montgomery, MS, RPh Director, Clinical Consulting, Omnicell The biggest vaccination campaign in history is now underway and scaling fast. The vaccine is finally here, and Omnicell is committed to helping you effectively manage and support a smooth rollout to your patients. million shots have been administered in the U.S.

article thumbnail

Advocates for Safe IV Preparation Practices Share Their Inspiration Podcast

Omnicell

Mark Neuenschwander Founding Director, THRIVCoalition.org Seminal research from 1997 on IV compounding discovered that 9 percent of manually compounded sterile preparations had incorrect ingredients and/or volumes. Worst yet, 74% of all respondents were aware of at least one pharmacy compounding error in the last 12 months.